| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/28/2006 | CN1792256A Health-care food for preventing and improving lead poisoning, and its prepn. method |
| 06/28/2006 | CN1792247A Health-care food with functions of anti-senium and cosmetic |
| 06/28/2006 | CN1792239A Jam made of yellow mallow |
| 06/28/2006 | CN1792199A Method for preparing soymilk contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792198A Method for preparing soymilk pellets contg. micron additives for tonifying-Yin and eliminating-fatgue |
| 06/28/2006 | CN1792197A Method for preparing soymilk powder contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792193A Method for preparing milk liquor contg. micron additives for tonifying-Yin and eliminating fatigue |
| 06/28/2006 | CN1792192A Method for preparing soymilk contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792191A Method for preparing milk pellets contg. micron additives for tonifying-Yin and eliminating-fatgue |
| 06/28/2006 | CN1792190A Method for preparing soymilk pellets contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792189A Method for preparing milk powder contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792188A Method for preparing soymilk powder contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792186A Method for preparing milk powder contg. micron additives for tonifying-Yin and nourishing of life |
| 06/28/2006 | CN1792185A Method for preparing soymilk powder contg. micron additives for tonifying-Yin and nourishing of life |
| 06/28/2006 | CN1792184A Method for preparing sour milk contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1792183A Method for sour soymilk contg. micron additives for tonifying-Yin and eliminating-fatigue |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261450C Antithrombotic compounds |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/28/2006 | CN1261419C Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 06/28/2006 | CN1261414C Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B) |
| 06/28/2006 | CN1261412C Indole derivatives as COXII inhibitors |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/28/2006 | CN1261145C Medicine for treating goiter |
| 06/28/2006 | CN1261102C Complement inhibitor |
| 06/28/2006 | CN1261100C Medicinal composition containing triphenyl-boroxin for boron neutron catching treatment |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261095C Brain, spinal and nerve injure treatment |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067657 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain |
| 06/27/2006 | US7067655 Adenosine A2a receptor antagonists |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067546 high yield, industrial scale crystallization of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (Candesartan) from solution or suspension with an aprotic polar solvent, between zero and 30 degrees Celsius |
| 06/27/2006 | US7067542 Diaminediols for the treatment of Alzheimer's disease |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067537 Anticancer, antitumor agents |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067528 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 06/27/2006 | US7067527 Thienopyridine derivatives, their production and use |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 06/27/2006 | US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067491 3,3,3-trifluoro-1-(methylethyl)-2-oxopropyl]carbamoyl}pyrrolidinyl) derivatives; useful for prophylaxis and treatment for various diseases caused by increased elastase activity, such as diseases caused by increased protein degradation by elastase, especially respiratory diseases |
| 06/27/2006 | US7067489 Hematopoietic stimulation |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067474 A peptide or polypeptide obtained from the armadillo domain of human beta -catenin polypeptide which inhibits the interaction of human beta -catenin polypeptide and a transcription factor or tumor suppressor protein |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067296 Enzymatic polypeptide for use in the treatment of pain, inflammation, arthritis, cancer and alzheimer's disease |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067261 Methods and compositions for treatment of central nervous system disorders |
| 06/27/2006 | US7067248 Screening method for orthopoxvirus antivirals |
| 06/27/2006 | US7067160 Three stage extraction using alcohol solvents |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067127 Amino and nucleotide sequences; isolated, hybrid nucleic acid; purification of enzyme |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006064975A1 Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity |
| 06/22/2006 | WO2006064957A1 Amide compound and thrombopoietin receptor activator |
| 06/22/2006 | WO2006064945A1 Process for producing muscarine receptor antagonist and intermediate therefor |
| 06/22/2006 | WO2006064914A1 Neuraminidase inhibitor |
| 06/22/2006 | WO2006064906A1 Amorphous composition |
| 06/22/2006 | WO2006064826A1 MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR |
| 06/22/2006 | WO2006064813A1 Nucleic acid construct and method of transferring mutation into target region by using the same |
| 06/22/2006 | WO2006064790A1 Apoptosis inducer for cancer cells, metastasis inhibitor for cancer cells, anticancer agent, food product, anti-hiv agent and food product having anti-hiv effect |
| 06/22/2006 | WO2006064761A1 Adiponectin regultor and foods, drinks, food aditives and drugs containing the same |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064686A1 Drug and method for preventing or relieving delayed nerve cell death |
| 06/22/2006 | WO2006063681A1 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 06/22/2006 | WO2006063639A1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 06/22/2006 | WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/22/2006 | WO2006027701A3 Fas associated factor 1 |
| 06/22/2006 | WO2006026380A3 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/22/2006 | WO2003061655A8 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135607 Drug for improving prognosis for subarachnoid hemorrhage |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |